Literature DB >> 8925281

Attenuation of c-Fos expression in the rat lumbosacral spinal cord by morphine or tramadol following noxious colorectal distention.

R J Traub1, S Stitt, G F Gebhart.   

Abstract

We have previously reported that repetitive, noxious colorectal distention (CRD) induces c-Fos in the lumbosacral spinal cord. This study examined the effects of the analgesics morphine and tramadol on c-Fos expression resulting from noxious CRD in the rat. Pre-treatment (30 min or 1 min, i.v.) with morphine (1.25 mg/kg-5.0 mg/kg) or tramadol (1 mg/kg-20 mg/kg) dose-dependently attenuated c-Fos expression to CRD in all areas of the L6-S1 spinal gray matter. The highest dose of morphine was equipotent to the highest dose of tramadol. Repetitive dosing (1/4 of the greatest dose every 30 min) was as effective as a single bolus dose for both drugs. The visceromotor response to CRD was dose-dependently attenuated by tramadol and was reversed by naloxone. However, the dose of tramadol that eliminated the visceromotor response (7% of control) reduced the c-Fos expression to 47% of control. These results demonstrate that these two analgesics attenuate immediate-early gene expression and the visceromotor response to a noxious visceral stimulus and suggest that complete attenuation of c-Fos expression is not necessary for these compounds to produce analgesia to a noxious visceral stimulus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8925281     DOI: 10.1016/0006-8993(95)00990-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Centrally acting agents and visceral sensitivity.

Authors:  J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels.

Authors:  Martina Mitrovic; Anaid Shahbazian; Elisabeth Bock; Maria A Pabst; Peter Holzer
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

Authors:  C M Kozlowski; A Green; D Grundy; F M Boissonade; C Bountra
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 4.  The role of experimental models in developing new treatments for irritable bowel syndrome.

Authors:  Daniel P Holschneider; Sylvie Bradesi; Emeran A Mayer
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

Review 5.  Studying the brain-gut axis with pharmacological imaging.

Authors:  Kirsten Tillisch; Zhuo Wang; Lisa Kilpatrick; Daniel P Holschneider; Emeran A Mayer
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

6.  Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity.

Authors:  Hong-Mei Jiao; Peng-Yan Xie
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.

Authors:  Justin Cy Wu; Eric Tc Ziea; Lixing Lao; Emma Fc Lam; Catherine Sm Chan; Angela Yq Liang; Sunny Lh Chu; David Tw Yew; Brian M Berman; Joseph Jy Sung
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

8.  Sex differences in the activation of the spinoparabrachial circuit by visceral pain.

Authors:  Anne Z Murphy; Shelby K Suckow; Malcolm Johns; Richard J Traub
Journal:  Physiol Behav       Date:  2009-03-09

9.  c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury?

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Open Pain J       Date:  2009-01-01

10.  Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord.

Authors:  Yi-Ning Sun; Jin-Yan Luo
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.